| abstract |
This invention provides a novel LXRbeta agonist that can be used as a preventing and/ or therapeutic agent of the following diseases: atherosclerosis, arterial sclerosis induced by diabetes and so on, lipid disorder, high hypercholesterolemia, lipid related diseases, inflammatory diseases induced by inflammatory cytokines, dermatosis such as allergic dermatosis, diabetes or Alzheimer's disease. This invention provides a carbinol compound represented by the following general formula (I), or the salts thereof or solvates thereof: [general formula (I)] |